Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nascimbeni

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Annales De Dermatologie Et De Venereologie|March 1, 2017
[Cutaneous involvement in T-lymphoblastic lymphoma]C Nascimbeni, S Chantepie, C Brugiere, et al.
The American Journal of Pathology|March 28, 2006
Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon diseaseMarina Fanin, Anna C Nascimbeni, Luigi Fulizio, et al.
Journal of Medical Genetics|May 29, 2007
Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2AM Fanin, L Nardetto, A C Nascimbeni, et al.
Neurology|April 22, 2009
Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypesM Fanin, A C Nascimbeni, S Aurino, et al.
Neurological Research|January 23, 2010
The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)C Angelini, L Nardetto, C Borsato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 4, 2006
Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype?C Pizzanelli, M Mancuso, R Galli, et al.
Muscle & Nerve|December 10, 2014
Incomplete penetrance in limb-girdle muscular dystrophy type 1FMarina Fanin, Enrico Peterle, Chiara Fritegotto, et al.
International Ophthalmology|February 19, 2026
Loading dose and 12-month outcomes in treatment-naïve patients with neovascular age-related macular degeneration treated with faricimab, with AI-based analysis of fluid dynamicsMickael Barbosa, Nicolò Bartolomeo, Yannic Pannatier Schuetz, et al.
European Journal of Ophthalmology|December 17, 2025
Pigment epithelial detachment as a biomarker for faricimab treatment outcomes in naïve neovascular age-related macular degenerationNicolò Bartolomeo, Mickael Barbosa, Yannic Pannatier Schuetz, et al.
Clinical Genetics|April 11, 2012
An intronic mutation causes severe LGMD2A in a large inbred family belonging to a genetic isolate in the AlpsM Fanin, F Benedicenti, C Fritegotto, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Annales De Dermatologie Et De Venereologie|March 1, 2017
[Cutaneous involvement in T-lymphoblastic lymphoma]C Nascimbeni, S Chantepie, C Brugiere, et al.
The American Journal of Pathology|March 28, 2006
Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon diseaseMarina Fanin, Anna C Nascimbeni, Luigi Fulizio, et al.
Journal of Medical Genetics|May 29, 2007
Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2AM Fanin, L Nardetto, A C Nascimbeni, et al.
Neurology|April 22, 2009
Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypesM Fanin, A C Nascimbeni, S Aurino, et al.
Neurological Research|January 23, 2010
The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)C Angelini, L Nardetto, C Borsato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 4, 2006
Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype?C Pizzanelli, M Mancuso, R Galli, et al.
Muscle & Nerve|December 10, 2014
Incomplete penetrance in limb-girdle muscular dystrophy type 1FMarina Fanin, Enrico Peterle, Chiara Fritegotto, et al.
International Ophthalmology|February 19, 2026
Loading dose and 12-month outcomes in treatment-naïve patients with neovascular age-related macular degeneration treated with faricimab, with AI-based analysis of fluid dynamicsMickael Barbosa, Nicolò Bartolomeo, Yannic Pannatier Schuetz, et al.
European Journal of Ophthalmology|December 17, 2025
Pigment epithelial detachment as a biomarker for faricimab treatment outcomes in naïve neovascular age-related macular degenerationNicolò Bartolomeo, Mickael Barbosa, Yannic Pannatier Schuetz, et al.
Clinical Genetics|April 11, 2012
An intronic mutation causes severe LGMD2A in a large inbred family belonging to a genetic isolate in the AlpsM Fanin, F Benedicenti, C Fritegotto, et al.
Pageof 3